The decrease of some serum free amino acids can predict breast cancer diagnosis and progression

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics. Cancer. J Clin. 2015;65:5–29.
   Google Scholar
• Sauter ER. The ongoing search for early detection biomarkers for breast cancer. Biomarkers Med. 2014;8:531–533.
   Web of Science ®Google Scholar
• Oskouie AA, Taheri S. Recent developments and application of metabolomics in cancer diseases. J Paramed Sci. 2015;6:116–134.
   Google Scholar
• Hart CD, Tenori L, Luchinat C, et al. Metabolomics in breast cancer: current status and perspectives. Adv Exp Med Biol. 2016;882:217–234.
   PubMed Web of Science ®Google Scholar
• Claudino WM, Quattrone A, Biganzoli L, et al. Metabolomics: available results, current research projects in breast cancer, and future applications. JCO. 2007;25:2840–2846.
   PubMed Web of Science ®Google Scholar
• Fan Y, Wang J, Yang Y, et al. Detection and identification of potential biomarkers of breast cancer. J Cancer Res Clin Oncol. 2010;136:1243–1254.
   PubMed Web of Science ®Google Scholar
• Jove M, Collado R, Quies JL, et al. A plasma metabolomic signature discloses human breast cancer. Oncotarget. 2017;8:19522–19533.
   PubMedGoogle Scholar
• Günther UL. Metabolomics biomarkers for breast cancer. Pathobiology. 2015;82:153–165.
   PubMed Web of Science ®Google Scholar
• Mishra P, Ambs S. Metabolic signatures of human breast cancer. Mol Cell Oncol. 2015;2:e992217.
   PubMed Web of Science ®Google Scholar
• Oakman C, Tenori L, Cappadona SS, et al. Targeting metabolomics in breast cancer. Curr Breast Cancer Rep. 2012;4:249–256.
   Google Scholar
• Shen J, Yan L, Liu S, et al. Metabolomic profiles in breast cancer patients and healthy controls: by race and tumor receptor subtypes. Transl Oncol. 2013; 6:757–765.
   PubMed Web of Science ®Google Scholar
• Armitage EG, Southam AD. Monitoring cancer prognosis, diagnosis and treatment efficacy using metabolomics and lipidomics. Metabolomics. 2016;12:146.
   PubMed Web of Science ®Google Scholar
• Cascino A, Muscaritoli M, Cangiano C, et al. Plasma amino acid imbalance in patients with lung and breast cancer. Anticancer Res. 1995;15:507–510.
   PubMed Web of Science ®Google Scholar
• Barnes T, Bell K, DiSebastiano KM, et al. Plasma amino acid profiles of breast cancer pacients early in the trajectory of the disease differ from healthy comparison groups. Appl Physiol Nutr Metab. 2014;39:740–744.
   PubMed Web of Science ®Google Scholar
• Lai HS, Lee JC, Lee PH, et al. Plasma free amino acid profile in cancer patients. Semin Cancer Biol. 2005;15:267–276.
   PubMed Web of Science ®Google Scholar
• Tsun ZY, Possemato R. Amino acid management in cancer. Semin Cell Dev Biol. 2015;43:22–32.
   PubMed Web of Science ®Google Scholar
• O'Connell TM. The complex role of branched chain amino acids in diabetes and cancer. Metabolites. 2013;3:931–945.
   PubMedGoogle Scholar
• Bi X, Henry CJ. Plasma-free amino acid profiles are predictors of cancer and diabetes development. Nutr Diabetes. 2017;7:e249.
   PubMed Web of Science ®Google Scholar
• Gu Y, Chen T, Fu S, et al. Perioperative dynamics and significance of amino acid profiles in patients with cancer. J Transl Med. 2015;13:35.
   PubMed Web of Science ®Google Scholar
• Miyagi Y, Igashiyama M, Gochi A, et al. Plasma free amino acid profiling of five types of cancer patients and its application for early detection. Plos One. 2011;6:e24143.
   PubMed Web of Science ®Google Scholar
• Proenza AM, Oliver J, Palou A, et al. Breast and lung cancer are associated with a decrease in blood cell amino acid content. J Nutr Biochem. 2003;14:133–138.
   PubMed Web of Science ®Google Scholar
• Nagata C, Wada K, Tsuji M, et al. Plasma amino acids profiles are associate with biomarkers of breast cancer risk in premenopausal Japanese women. Cancer Causes Control. 2014;25:143–149.
   PubMed Web of Science ®Google Scholar
• Okamoto N, Chiba A, Miyagi Y, et al. Alternative method for the diagnosis of early breast cancer using plasma free amino acid profiles. The Breast. 2007;16:S22.
   Web of Science ®Google Scholar
• Poschke I, Mao Y, Kiessling R, et al. Tumor-dependent increase of serum amino acid levels in breast cancer patients has diagnostic potential and correlates with molecular tumor subtypes. J Transl Med. 2013;11:290–298.
   PubMed Web of Science ®Google Scholar
• Okamoto N. Use of 'AminoIndex Technology' for cancer screening. Ningen Dock. 2012;26:911–922.
   Google Scholar
• Amelio I, Cutruzzola F, Antonov A, et al. Serine and glycine metabolism in cancer. Trends Biochem Sci. 2014;39:191–198.
   PubMed Web of Science ®Google Scholar
• Kim SK, Jung WH, Koo JS. Differential expression of enzymes associated with serine/glycine metabolism in different breast cancer subtypes. PLoS One. 2014;9:e101004.
   PubMed Web of Science ®Google Scholar
• Labuschagne CF, van den Broek NJ, Mackay GM, et al. Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. Cell Rep. 2014;7:1248–1258.
   PubMed Web of Science ®Google Scholar
• Possemato R, Marks KM, Shaul YD, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature. 2011; 476:346–350.
   PubMed Web of Science ®Google Scholar
• Jain M, Nilsson R, Sharma S, et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science. 2012; 336:1040–1044.
   PubMed Web of Science ®Google Scholar
• Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci. 2010; 35:427–433.
   PubMed Web of Science ®Google Scholar
• Alberghina L, Gaglio D. Redox control of glutamine utilization in cancer. Cell Death Dis. 2014;5:e1561
   PubMed Web of Science ®Google Scholar
• Korangath P, Teo WW, Sadik H, et al. Targeting glutamine metabolism in breast cancer with aminooxyacetate. Clin Cancer Res. 2015;21:3263–3273.
   PubMed Web of Science ®Google Scholar
• Medina MA. Glutamine and cancer. J Nutr. 2001;131:2539S–2542S. discussion 2550S-1S.
   PubMed Web of Science ®Google Scholar
• Romanciuc F, Eniu D, Staicu A, et al. HPLC/MS-based metabolic profiling and quantification of urine free amino acids as potential biomarkers for breast cancer diagnosis and progression. Bull UASVM Animal Sci Biotechnol. 2015;72:226–235.
   Google Scholar
• Slupsky CM, Steed H, Wells TH, et al. Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers. Clin Cancer Res. 2010;16:5835–5841.
   PubMed Web of Science ®Google Scholar
• Muñoz-Pinedo C, El Mjiyad N, Ricci JE. Cancer metabolism: current perspectives and future directions. Cell Death Dis. 2012;3:e248.
   PubMed Web of Science ®Google Scholar
• Beger RD. A review of applications of metabolomics in cancer. Metabolites. 2013;3:552–574.
   PubMedGoogle Scholar
• Schulze A, Harris AL. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature. 2012;491:364–373.
   PubMed Web of Science ®Google Scholar
• Lind DS. Arginine and cancer. J Nutr. 2004;134:2837S–2841S. discussion 2853S.
   PubMed Web of Science ®Google Scholar
• Vissers YL, Dejong CH, Luiking YC, et al. Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency? Am J Clin Nutr. 2005;81:1142–1146.
   PubMed Web of Science ®Google Scholar
• Xia J, Wishart DS. Using MetaboAnalyst 3.0 for comprehensive metabolomics data analysis. Curr Protoc Bioinformatics. 2016;55:14.10.1–14.10.91.
   Google Scholar